Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 2 (2024)

The magnitude of the plasma hepcidin response to oral iron supplements depends on the iron dosage

  • Maximilian Karczewski
  • Stana Simic
  • Lanja Saleh
  • Albina Nowak
  • Morton G. Schubert
  • Diego Moretti
  • Dorine W. Swinkels
  • Felix Beuschlein
  • Paolo M. Suter
  • Pierre-Alexandre Krayenbuehl
DOI
https://doi.org/10.57187/s.3635
Cite this as:
Swiss Med Wkly. 2024;154:3635
Published
19.02.2024

Summary

BACKGROUND: Iron deficiency without anaemia is a common health problem, especially in young menstruating women. The efficacy of the usually recommended oral iron supplementation is limited due to increased plasma hepcidin concentration, which reduces iron absorption and leads to side effects such as intestinal irritation. This observation raises the question of how low-dose iron therapy may affect plasma hepcidin levels and whether oral iron intake dose-dependently affects plasma hepcidin production.

METHODS: Fifteen non-anaemic women with iron deficiency (serum ferritin ≤30 ng/ml) received a single dose of 0, 6, 30, or 60 mg of elemental oral iron as ferrous sulfate on different days. Plasma hepcidin was measured before and seven hours after each dose.

RESULTS: Subjects had an average age of 23 (standard deviation = 3.0) years and serum ferritin of 24 ng/ml (interquartile range = 16–27). The highest mean change in plasma hepcidin levels was measured after ingesting 60 mg of iron, increasing from 2.1 ng/ml (interquartile range = 1.6–2.9) to 4.1 ng/ml (interquartile range = 2.5–6.9; p < 0.001). Iron had a significant dose-dependent effect on the absolute change in plasma hepcidin (p = 0.008), where lower iron dose supplementation resulted in lower plasma hepcidin levels. Serum ferritin levels were significantly correlated with fasting plasma hepcidin levels (R2 = 0.504, p = 0.003) and the change in plasma hepcidin concentration after iron intake (R2 = 0.529, p = 0.002).

CONCLUSION: We found a dose-dependent effect of iron supplementation on plasma hepcidin levels. Lower iron dosage results in a smaller increase in hepcidin and might thus lead to more efficient intestinal iron absorption and fewer side effects. The effectiveness and side effects of low-dose iron treatment in women with iron deficiency should be further investigated.

This study was registered at the Swiss National Clinical Trials Portal (2021-00312) and ClinicalTrials.gov (NCT04735848).

References

  1. Kassebaum NJ, Collaborators GA; GBD 2013 Anemia Collaborators. The Global Burden of Anemia. Hematol Oncol Clin North Am. 2016 Apr;30(2):247–308. 10.1016/j.hoc.2015.11.002 DOI: https://doi.org/10.1016/j.hoc.2015.11.002
  2. C. Camaschella, "Iron-Deficiency Anemia," (in eng), N Engl J Med, vol. 373, no. 5, pp. 485-6, 07 30 2015, doi: 10.1056/NEJMc1507104. 10.1056/NEJMra1401038 DOI: https://doi.org/10.1056/NEJMc1507104
  3. DeLoughery TG. Iron Deficiency Anemia. Med Clin North Am. 2017 Mar;101(2):319–32. 10.1016/j.mcna.2016.09.004 DOI: https://doi.org/10.1016/j.mcna.2016.09.004
  4. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011 Sep;118(12):3222–7. 10.1182/blood-2011-04-346304 DOI: https://doi.org/10.1182/blood-2011-04-346304
  5. Scott SP, Murray-Kolb LE. Iron Status Is Associated with Performance on Executive Functioning Tasks in Nonanemic Young Women. J Nutr. 2016 Jan;146(1):30–7. 10.3945/jn.115.223586 DOI: https://doi.org/10.3945/jn.115.223586
  6. Beatrix J, Piales C, Berland P, Marchiset E, Gerbaud L, Ruivard M. “Non-anemic iron deficiency: correlations between symptoms and iron status parameters,” (in eng). Eur J Clin Nutr. 2021 Nov; 10.1038/s41430-021-01047-5 DOI: https://doi.org/10.1038/s41430-021-01047-5
  7. Snook J, Bhala N, Beales IL, Cannings D, Kightley C, Logan RP, et al. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. 2021 Nov;70(11):2030–51. 10.1136/gutjnl-2021-325210 DOI: https://doi.org/10.1136/gutjnl-2021-325210
  8. D. Moretti, "Novel approaches to oral iron treatment," (in eng), Hemasphere, vol. 3, no. Suppl, Jun 2019, doi: 10.1097/HS9.0000000000000235. DOI: https://doi.org/10.1097/HS9.0000000000000235
  9. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G199–203. 10.1152/ajpgi.00412.2005 DOI: https://doi.org/10.1152/ajpgi.00412.2005
  10. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004 Dec;306(5704):2090–3. 10.1126/science.1104742 DOI: https://doi.org/10.1126/science.1104742
  11. Young MF, Glahn RP, Ariza-Nieto M, Inglis J, Olbina G, Westerman M, et al. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr. 2009 Feb;89(2):533–8. 10.3945/ajcn.2008.26589 DOI: https://doi.org/10.3945/ajcn.2008.26589
  12. V. Sangkhae and E. Nemeth, "Regulation of the Iron Homeostatic Hormone Hepcidin," (in eng), Adv Nutr, vol. 8, no. 1, pp. 126-136, 01 2017, doi: 10.3945/an.116.013961. DOI: https://doi.org/10.3945/an.116.013961
  13. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015 Oct;126(17):1981–9. 10.1182/blood-2015-05-642223 DOI: https://doi.org/10.1182/blood-2015-05-642223
  14. Hahn PF, Bale WF, Ross JF, Balfour WM, Whipple GH. “RADIOACTIVE IRON ABSORPTION BY GASTRO-INTESTINAL TRACT : INFLUENCE OF ANEMIA, ANOXIA, AND ANTECEDENT FEEDING DISTRIBUTION IN GROWING DOGS,” (in eng). J Exp Med. 1943 Sep;78(3):169–88. 10.1084/jem.78.3.169 DOI: https://doi.org/10.1084/jem.78.3.169
  15. Cook JD, Reddy MB. Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr. 1995 Jul;62(1):117–20. 10.1093/ajcn/62.1.117 DOI: https://doi.org/10.1093/ajcn/62.1.117
  16. Richards T, Breymann C, Brookes MJ, Lindgren S, Macdougall IC, McMahon LP, et al. Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Ann Med. 2021 Dec;53(1):274–85. 10.1080/07853890.2020.1867323 DOI: https://doi.org/10.1080/07853890.2020.1867323
  17. Ribeiro M, Fonseca L, Anjos JS, Capo-Chichi JC, Borges NA, Burrowes J, et al. Oral iron supplementation in patients with chronic kidney disease: can it be harmful to the gut microbiota? Nutr Clin Pract. 2022 Feb;37(1):81–93. 10.1002/ncp.10662 DOI: https://doi.org/10.1002/ncp.10662
  18. Simic S, Karczewski M, Klapdor S, Nowak A, Schubert M, Moretti D, et al. Effectiveness of low-dose iron treatment in non-anaemic iron-deficient women: a prospective open-label single-arm trial. Swiss Med Wkly. 2023 May;153(5):40079. 10.57187/smw.2023.40079 DOI: https://doi.org/10.57187/smw.2023.40079
  19. Rosado JL, González KE, Caamaño MC, García OP, Preciado R, Odio M. Efficacy of different strategies to treat anemia in children: a randomized clinical trial. Nutr J. 2010 Sep;9(1):40. 10.1186/1475-2891-9-40 DOI: https://doi.org/10.1186/1475-2891-9-40
  20. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, Namir M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005 Oct;118(10):1142–7. 10.1016/j.amjmed.2005.01.065 DOI: https://doi.org/10.1016/j.amjmed.2005.01.065

Most read articles by the same author(s)